What is the control range of TG in hemisection of thyroid cancer

The range of TSH (thyroid-stimulating hormone) control in hemisection of thyroid cancer needs to be determined under the guidance of a doctor based on factors such as the type of thyroid cancer and the severity of the disease, combined with the patient's own situation.

1. Primary thyroid cancer: For patients with primary thyroid cancer, if the condition is mild and there is no metastasis to other parts, while inhibiting the growth of cancer cells, it is also necessary to control TSH within a good range. Thyroid hormone suppression therapy can be used under the guidance of a doctor. Generally, TSH needs to be controlled at 2-4mU/L;

2. Papillary thyroid carcinoma: Papillary thyroid carcinoma is a common type of thyroid cancer. It has a low degree of malignancy, slow development, and a good prognosis. TSH suppression therapy is not routinely required after surgery. If the patient is in the late stage of papillary thyroid carcinoma, the TSH level should also be controlled within a good range, and the thyroid hormone can be suppressed to below 1.5mU/L;

3. Follicular thyroid carcinoma: Distant metastasis is common in follicular thyroid carcinoma, and the prognosis is poor. TSH suppression therapy is indispensable after surgery, and is generally controlled at 0.5-2.0 mU/L;

4. Medullary carcinoma: The incidence of distant metastasis of medullary carcinoma is high, and the harm to patients is also relatively large. TSH suppression therapy is routinely required after surgery, and it is generally controlled at 0.5-2.0mU/L.

When thyroid cancer patients undergo TSH suppression therapy, they need to strictly control the TSH range. They also need to pay attention to changes in thyroid function after surgery, radiotherapy, and chemotherapy, and to supplement thyroid hormone tablets when undergoing thyroid hormone suppression therapy.